caprotec bioanalytics GmbH Appoints Dr. Mathias Grote as Chief Financial and Chief Operating Officer
caprotec bioanalytics GmbH announced the appointment of Dr. Mathias Grote as Chief Financial Officer and Chief Operating Officer of the Company. Before joining caprotec bioanalytics, Dr. Grote held various senior management positions within the pharmaceutical and biotech industry, most recently as CEO of Pelias AG. Positions held prior to that included Senior Vice President of Commercial Operations at Intercell AG, Chief Business Officer of Noxxon AG, and 15 years at Chiron Vaccines (formerly Behring).
"We are delighted to have Dr. Grote join our management team," said caprotec founder and CEO Prof. Dr. Hubert Köster. "His outstanding senior-level track record within the biopharmaceutical industry, specifically with product commercialization and creating key pharmaceutical partnerships, will be of particular importance as the Company prepares to commercialize it's proprietary CCMS technology and it's exciting IMPROMED application to investigate the mechanism of drug action and to identify and reduce side effects of small molecules."
Other news from the department people
